Firebrick Pharma Limited
FRE
Rank in Stocks
#30469
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered... Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Share Price
$0.01923025
Last synced: 2026-11-09
Market Cap
$5.05M
Change (1 day)
-0.78%
Change (1 year)
-53.31%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Firebrick Pharma Limited (FRE)
Category
Healthcare
EPS for Firebrick Pharma Limited (FRE)
EPS as of June 2026 TTM: $-0.01
According to Firebrick Pharma Limited's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.01, a decrease compared to its 2024 EPS of 0.00.
EPS history for Firebrick Pharma Limited from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -15.00% |
| 2025 | $-0.01 | 86.36% |
| 2024 | 0.00 | -83.52% |
| 2023 | $-0.03 | 72.26% |
| 2022 | $-0.02 | 43.52% |
| 2021 | $-0.01 | 77.05% |
| 2020 | $-0.01 | 103.33% |
| 2019 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.89 | -363,511.76% |
US
|
|
| $6.60 | -77,747.06% |
US
|
|
| $5.83 | -68,688.24% |
US
|
|
| $0.98 | -11,629.41% |
US
|
|
| $18.54 | -218,241.18% |
CH
|
Questions about Firebrick Pharma Limited's earnings per share (EPS)
What is Firebrick Pharma Limited's earnings per share (EPS)?
Firebrick Pharma Limited's earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was Firebrick Pharma Limited's earnings per share (EPS) in 2025?
In 2025, Firebrick Pharma Limited's earnings per share (EPS) was $-0.01, compared with 0.00 in 2024.
How has Firebrick Pharma Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Firebrick Pharma Limited's earnings per share (EPS) was highest in 2024 (0.00) and lowest in 2023 ($-0.03).
How does Firebrick Pharma Limited's earnings per share (EPS) compare with similar companies?
Firebrick Pharma Limited's earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Eli Lilly and Company, with $30.89.